Several healthcare and biotech stocks posted solid gains in Tuesday's after-hours session, with most moves occurring without company-specific news.
Acumen Pharmaceuticals, Inc. (ABOS) advanced 8.09% to close at $2.94 after hours, adding $0.22 to its share price.
Fulgent Genetics, Inc. (FLGT) rose 5.98% to $28.90 as of 6:59 p.m. EST, gaining $1.63 in extended trading.
Fractyl Health, Inc. (GUTS) climbed 5.19% to $2.23, up $0.11 after hours.
Coeptis Therapeutics Holdings, Inc. (COEP) added 4.14% to finish at $13.85 as of 7:22 p.m. EST, a gain of $0.55.
Jin Medical International Ltd. (ZJYL) increased 4.04% to $0.16, up $0.0061. The company recently announced that its Chief Executive Officer and management team will host a fireside chat on February 1, 2026, at 8:00 p.m. EST to discuss strategic priorities and long-term growth considerations.
Alignment Healthcare, Inc. (ALHC) gained 5.92% to $22.20, adding $1.24 in after-hours trading.
Orthofix Medical Inc. (OFIX) rose 4.58% to $13.94 as of 6:07 p.m. EST, up $0.61.
Alto Neuroscience, Inc. (ANRO) advanced 4.52% to $17.57 as of 6:53 p.m. EST, gaining $0.76.
Immix Biopharma, Inc. (IMMX) increased 3.87% to $6.17 as of 7:58 p.m. EST, adding $0.23.
Amneal Pharmaceuticals, Inc. (AMRX) rose 3.76% to $14.35, up $0.52 in after-hours trading. The company is set to replace TTM Technologies in the S&P SmallCap 600 index effective prior to the opening of trading on Friday, January 30.
Tyra Biosciences, Inc. (TYRA) gained 3.76% to $32.58 as of 7:23 p.m. EST, adding $1.18 in extended trading.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.